Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...

With the holidays past and the new year arrived, we look ahead — to losing weight. For some that resolve theoretically ...

We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.

Weight loss jabs such as Wegovy are “lifelong treatments” and most people who stop taking them will lose the effects, a ...

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

It's not just celebrities and TikTok creators jumping on the weight loss drug hype - more than 500,000 people in the UK are ...

The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

More than 90 per cent of weight loss jab users are forced to pay for treatment privately due to their slow roll-out on the ...

Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Drugs like Ozempic and Wegovy are now costing Connecticut taxpayers about $60 million this year and that figure could rise ...

A new generation of weight loss drugs has helped some people lose significant amounts of weight and improve their health.